Galloflavin can inhibit the malignant behavior of colorectal cancer cells in the inflammatory microenvironment by targeting NLRP3, which is an important mechanism underlying the inhibitory effect of galloflavin on colorectal cancer progression. This evidence concerns the gene NLRP3 and colorectal cancer.